'Developing a new drug is stumbling in the dark without a map. We are building the GPS'
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
Site référencé:
Haaretz
